Sung Ji Nam
Stock Analyst at Scotiabank
(1.96)
# 2,828
Out of 4,829 analysts
75
Total ratings
38.1%
Success rate
-8.84%
Average return
Main Sectors:
Stocks Rated by Sung Ji Nam
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| GH Guardant Health | Maintains: Sector Outperform | $52 → $57 | $42.06 | +35.52% | 5 | May 5, 2025 | |
| TMO Thermo Fisher Scientific | Maintains: Sector Perform | $650 → $605 | $426.55 | +41.84% | 14 | Apr 25, 2025 | |
| BNGO Bionano Genomics | Maintains: Sector Perform | $1 → $4 | $3.94 | +1.52% | 6 | Apr 2, 2025 | |
| MYGN Myriad Genetics | Maintains: Sector Outperform | $24 → $20 | $3.95 | +406.33% | 3 | Apr 1, 2025 | |
| PACB Pacific Biosciences of California | Maintains: Sector Outperform | $6 → $2 | $1.13 | +76.99% | 5 | Mar 25, 2025 | |
| EXAS Exact Sciences | Maintains: Sector Outperform | $70 → $73 | $52.57 | +38.86% | 2 | Feb 24, 2025 | |
| ADPT Adaptive Biotechnologies | Maintains: Sector Outperform | $10 → $12 | $9.53 | +25.92% | 2 | Feb 13, 2025 | |
| WAT Waters | Upgrades: Sector Outperform | $430 → $450 | $362.58 | +24.11% | 2 | Feb 13, 2025 | |
| TECH Bio-Techne | Maintains: Sector Outperform | $88 → $90 | $52.92 | +70.07% | 2 | Feb 6, 2025 | |
| TWST Twist Bioscience | Maintains: Sector Outperform | $54 → $62 | $32.24 | +92.34% | 5 | Feb 4, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Perform | $265 | $196.91 | +34.58% | 1 | Dec 23, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $40 → $44 | $30.31 | +45.17% | 4 | Nov 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $37 → $44 | $16.94 | +159.74% | 5 | Nov 6, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Buy | $40 → $35 | $15.66 | +123.50% | 4 | Nov 5, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiates: Sector Outperform | $3 | $0.36 | +733.10% | 1 | Sep 16, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintains: Sector Outperform | $176 → $164 | $80.31 | +104.21% | 9 | Aug 15, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Assumes: Buy | $6 | $6.87 | -12.66% | 2 | Jun 29, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgrades: Neutral | n/a | $19.93 | - | 3 | Nov 24, 2020 |
Guardant Health
May 5, 2025
Maintains: Sector Outperform
Price Target: $52 → $57
Current: $42.06
Upside: +35.52%
Thermo Fisher Scientific
Apr 25, 2025
Maintains: Sector Perform
Price Target: $650 → $605
Current: $426.55
Upside: +41.84%
Bionano Genomics
Apr 2, 2025
Maintains: Sector Perform
Price Target: $1 → $4
Current: $3.94
Upside: +1.52%
Myriad Genetics
Apr 1, 2025
Maintains: Sector Outperform
Price Target: $24 → $20
Current: $3.95
Upside: +406.33%
Pacific Biosciences of California
Mar 25, 2025
Maintains: Sector Outperform
Price Target: $6 → $2
Current: $1.13
Upside: +76.99%
Exact Sciences
Feb 24, 2025
Maintains: Sector Outperform
Price Target: $70 → $73
Current: $52.57
Upside: +38.86%
Adaptive Biotechnologies
Feb 13, 2025
Maintains: Sector Outperform
Price Target: $10 → $12
Current: $9.53
Upside: +25.92%
Waters
Feb 13, 2025
Upgrades: Sector Outperform
Price Target: $430 → $450
Current: $362.58
Upside: +24.11%
Bio-Techne
Feb 6, 2025
Maintains: Sector Outperform
Price Target: $88 → $90
Current: $52.92
Upside: +70.07%
Twist Bioscience
Feb 4, 2025
Maintains: Sector Outperform
Price Target: $54 → $62
Current: $32.24
Upside: +92.34%
Dec 23, 2024
Initiates: Sector Perform
Price Target: $265
Current: $196.91
Upside: +34.58%
Nov 8, 2024
Maintains: Sector Outperform
Price Target: $40 → $44
Current: $30.31
Upside: +45.17%
Nov 6, 2024
Maintains: Sector Outperform
Price Target: $37 → $44
Current: $16.94
Upside: +159.74%
Nov 5, 2024
Maintains: Buy
Price Target: $40 → $35
Current: $15.66
Upside: +123.50%
Sep 16, 2024
Initiates: Sector Outperform
Price Target: $3
Current: $0.36
Upside: +733.10%
Aug 15, 2024
Maintains: Sector Outperform
Price Target: $176 → $164
Current: $80.31
Upside: +104.21%
Jun 29, 2023
Assumes: Buy
Price Target: $6
Current: $6.87
Upside: -12.66%
Nov 24, 2020
Downgrades: Neutral
Price Target: n/a
Current: $19.93
Upside: -